Benzinga | Oct 21, 2021 12:11PM EDT

HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $2.5

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (NASDAQ:EVFM) with a Buy and lowers the price target from $4 to $2.5.